We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 496

2016 Global Data Breach Notification Guide
  • Baker & McKenzie
  • United Kingdom, USA, Canada, France, Ireland
  • August 1 2016

In your jurisdiction, are there legal requirements for organizations to provide notice of a breach of security for personal data or other company


Mental health, taking of blood samples without patient consent
  • Matheson
  • Ireland
  • February 1 2012

Mr Justice MacMenamin in his judgement dated 26 July 2011, held that the taking of blood samples by doctors treating a woman suffering from severe mental illness was lawful, despite her failure to give consent


Workplace Policy Institute Insider Report September 2016
  • Littler Mendelson PC
  • Ireland, USA
  • September 2 2016

August is typically a slow month in Washington. When Congress is out of session, there is an exodus from the hot and humid Capital. However, with


Liability at common law of a parent company to an employee of its subsidiary
  • A&L Goodbody
  • Ireland, United Kingdom
  • September 20 2011

In a recent UK High Court case a parent company was held to owe a duty of care to an employee of a subsidiary company, where the employee had been exposed to asbestos and subsequently suffered asbestosis, in circumstances where the subsidiary company was no longer in existence


A warning to disciplinary panels of regulatory bodies: the impact of “Bloodgate” goes beyond sport
  • A&L Goodbody
  • Ireland, United Kingdom
  • August 15 2011

Many people will remember the infamous fake blood incident that tarnished the sport of rugby union which became known as “Bloodgate”


Interim injunctions and the pharmaceutical industry in Ireland
  • Matheson
  • Ireland
  • February 4 2011

The launch of a generic product onto the marketplace in competition with a patented pharmaceutical product can have devastating effects on an originator company's market position and pricing strategy


Irish patent perspectives pharmaceutical revocation actions, an obvious step in the right direction?
  • Matheson
  • Ireland
  • December 31 2009

The recent Commercial Court case of Glaxo Group Limited v Patents Act (2009) is the only Irish decision in recent times to deal with the revocation of a patent on the grounds of lack of inventive step


Allegations of mis-selling could not be considered by Financial Services Ombudsman when they occurred more than six years previously
  • A&L Goodbody
  • Ireland
  • April 28 2015

In Geoghegan v Financial Services Ombudsman & Ors 2015 IEHC 217, Kearns P in the High Court rejected an appeal of a decision of the Financial


Short Note: foreign teenagers, medical treatment and the inherent jurisdiction
  • 39 Essex Chambers
  • European Union, Ireland, United Kingdom
  • April 13 2016

In Re Z 2016 EWHC 784 (Fam), Baker J had to consider the exercise of the court's powers under the inherent jurisdiction to recognise and enforce


Pre-action Protocols and the Extension of Time Limits
  • William Fry
  • Ireland
  • December 3 2015

Provisions allowing for pre-action protocols in clinical negligence actions are finally to be introduced, five years after they were advised by the